Company Overview
Snapshot
Founded in April 2025 by Effie Arditi, Neil Panchal, and Gaby Hayon, Longevitix operates with 1–10 employees. The company has raised $3.5M across one funding round from 4 investors. In May 2026, Longevitix secured its Pre-Seed funding round.
Business overview
Longevitix develops an AI-driven platform designed to assist physician practices in delivering preventive and longevity-focused care. Its core technology automates patient enrollment, analyzes health data to identify risk factors, and generates personalized intervention plans. The platform integrates laboratory results and biomarkers into a unified view, utilizing automated diagnostics to support clinical decision-making and ongoing patient management. Longevitix serves the healthcare industry, specifically targeting providers, to streamline administrative and analytical processes for implementing predictive and personalized care models.
Strategic signal
In March 2026, Longevitix was named a Catalyst Partner for The Longevity Show 2026. This partnership signals significant industry recognition and strategic alignment within the longevity and health technology sectors, positioning Longevitix for increased visibility and potential collaborations in a rapidly evolving market.
Log in to access full profile ›Company Intelligence Q&A
- When was Longevitix founded?
- Longevitix was founded in April 2025.
- Who are the founders of Longevitix?
- Longevitix was founded by Effie Arditi, Neil Panchal, and Gaby Hayon.
- What is Longevitix's primary sector?
- Longevitix's primary sector is Health Tech & Life Sciences.
- What was a key strategic development for Longevitix in early 2026?
- In March 2026, Longevitix was named a Catalyst Partner for The Longevity Show 2026, highlighting its growing presence and strategic importance in the longevity technology space.
- Which investors participated in Longevitix's Pre-Seed funding round?
- In May 2026, Longevitix secured Pre-Seed funding from investors including SeedIL Ventures.